EGFR and non-small cell lung carcinoma: For example, previous studies have demonstrated that EGFR mutation-positive NSCLC did not show primary tumors larger than 30 mm in size with internal low-density areas frequently (10%), while pleural invasion was reported to be almost 50% [29–31].